GenomOncology said it will integrate Pacific Biosciences’ HiFi whole-genome sequencing secondary analysis pipeline into its Pathology Workbench reporting platform. The integration aims to streamline the translation of long-read WGS outputs into clinician-ready reports, including variant interpretation and QC review. The workflow combines PacBio’s research-use-only secondary analysis with Pathology Workbench’s tertiary layer, which includes evidence curation and report generation. GenomOncology said the approach will standardize upstream sequencing while allowing tailoring by tumor type, myeloid-focused panels, and clinical or reimbursement needs. This is positioned as an operational advance for labs adopting long-read sequencing at scale—an area where clinical usability, standardization, and reporting consistency can determine adoption velocity.